Thomas D'Alonzo, Director at SALIX PHARMACEUTICALS LTD (SLXP), sold 22,500 shares at $10.40 ($227K) on 2009-05-11, disclosed to the SEC on 2009-05-13.
Open-market sale of $227k SLXP by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.40 | 7,500 | $78K | 34.3% |
| 2 | $10.40 | 7,500 | $78K | 34.3% |
| 3 | $9.48 | 7,500 | $71K | 31.3% |
| Total | $10.09 avg | 22,500 | $227K | 100% |
| Filing → |
| SLXP | SELL | 2013-04-10 | $307K | — | Filing → |
| SLXP | SELL | 2012-06-12 | $493K | — | Filing → |
| SLXP | SELL | 2011-12-08 | $209K | — | Filing → |